Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1026-05-7 | MDL No. : | MFCD00183927 |
Formula : | C16H18N2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | FTECJLOPKLYFII-UHFFFAOYSA-N |
M.W : | 238.33 g/mol | Pubchem ID : | 2839906 |
Synonyms : |
|
Num. heavy atoms : | 18 |
Num. arom. heavy atoms : | 12 |
Fraction Csp3 : | 0.25 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 0.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 79.98 |
TPSA : | 24.06 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | Yes |
Log Kp (skin permeation) : | -4.93 cm/s |
Log Po/w (iLOGP) : | 2.63 |
Log Po/w (XLOGP3) : | 3.98 |
Log Po/w (WLOGP) : | 2.96 |
Log Po/w (MLOGP) : | 3.06 |
Log Po/w (SILICOS-IT) : | 2.84 |
Consensus Log Po/w : | 3.09 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -4.19 |
Solubility : | 0.0155 mg/ml ; 0.0000651 mol/l |
Class : | Moderately soluble |
Log S (Ali) : | -4.19 |
Solubility : | 0.0155 mg/ml ; 0.0000651 mol/l |
Class : | Moderately soluble |
Log S (SILICOS-IT) : | -5.78 |
Solubility : | 0.000396 mg/ml ; 0.00000166 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 2.0 |
Synthetic accessibility : | 2.86 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
82% | With DPZ In chloroform; toluene at 25℃; for 15 h; Molecular sieve; Sealed tube; Irradiation; Green chemistry | Will dissolve in 200μLOrganic photocatalyst DPZ in toluene (0.28 mg, 0.0008 mmol)Take a 10mL reaction flask,Dry the toluene with an air pump and add 66 mg (0.4 mmol)2-phenylaminopropionic acid and 100mg 4Å molecular sieves,Then add 4mL purified and dried chloroform and seal the bottle mouth with a rubber stopper.And insert a balloon filled with dry air. Place the reaction flask in a 25°C incubator.The reaction was stirred for 15 hours under the irradiation of two 1W blue LED lamps.After the reaction is complete, use a rotary evaporator to distill 2/3 of the solution.Separation by column chromatography (hexane/ethyl acetate 60-30:1)That is, 39.1 mg of 2-methyl-4-N-phenyl-tetrahydroquinolin-4-amine are obtained as a colorless oily liquid.The yield was 82percent. |
[ 2061996-91-4 ]
(R)-3-(Pyrrolidin-2-yl)aniline hydrochloride
Similarity: 0.81
[ 147769-93-5 ]
(S)-3-Methyl-1-(2-(piperidin-1-yl)phenyl)butan-1-amine
Similarity: 0.79
[ 801156-77-4 ]
1,2,3,4-Tetrahydroquinolin-4-amine
Similarity: 0.98
[ 1416354-44-3 ]
7-Methyl-2,3,4,5-tetrahydro-1H-benzo[b]azepin-5-amine dihydrochloride
Similarity: 0.88
[ 61894-99-3 ]
2,3,4,9-Tetrahydro-1H-carbazol-3-amine
Similarity: 0.86
[ 116650-33-0 ]
(R)-2,3,4,9-Tetrahydro-1H-carbazol-3-amine
Similarity: 0.86
[ 1263284-26-9 ]
1,2,3,4-Tetrahydrocyclopenta[b]indol-2-amine
Similarity: 0.84
[ 801156-77-4 ]
1,2,3,4-Tetrahydroquinolin-4-amine
Similarity: 0.98
[ 19343-79-4 ]
2,4-Dimethyl-1,2,3,4-tetrahydroquinoline
Similarity: 0.84
[ 52601-70-4 ]
8-Methyl-1,2,3,4-tetrahydroquinoline
Similarity: 0.83